期刊文献+

中国部分地区淋球菌耐药监测点产青霉素酶淋球菌及其 blaTEM-135突变体的流行调查 被引量:4

Penicillinase-producing Neisseria gonorrhoeae and its blaTEM-135 gene variants at several gonococcal antimicrobial surveillance sites in China:an epidemiological study
原文传递
导出
摘要 目的:了解中国不同地区淋球菌耐药监测点产青霉素酶淋球菌(PPNG)的比例及 blaTEm-135突变体在 PPNG 中的分布,比较 PPNG 及 blaTEm-135突变体淋球菌多抗原测序分型(NG-MAST)的型别分布,了解不同地区 PPNG blaTEm-135突变体的差异与联系。方法2012年在江苏、上海、浙江、天津、广东、广西6个淋球菌耐药监测点共收集572株淋球菌,经过分离纯化及鉴定后,采用头孢噻吩纸片法测定 PPNG;菌株培养后利用试剂盒提取 DNA,通过错配扩增突变分析 PCR(MAMA PCR)鉴定 blaTEm-135突变体,采用 NG-MAST 进行分型研究。结果572株淋球菌中 PPNG 总阳性率为38.1%(218/572),PPNG 中相应 blaTEm-135突变体的总比例为52.3%(114/218)。监测点中 PPNG 阳性率从高至低分别为:浙江(45/87,51.7%)、上海(36/79,45.6%)、广东(78/205,38.0%)、广西(12/32,37.5%)、江苏(24/77,31.2%)、天津(23/92,25%);PPNG 中相应 blaTEm-135突变体的阳性率从高至低分别为:浙江(31/45,68.9%)、江苏(14/24,58.3%)、广东(39/78,50.0%)、上海(17/36,47.2%)、天津(9/23,39.1%)、广西(4/12,33.3%)。 NG-MAST 分型研究显示,blaTEm-135突变体中流行菌株型别有 ST2318、ST1768、ST1866、ST1053、ST8726等,其中 ST1768、ST1053和 ST8726与 blaTEm-135突变体有较强的对应关系。天津 PPNG 菌株及 blaTEm-135突变体 ST 分布与其他各监测点有显著差异,江浙沪地区菌株 ST 有一定联系。结论中国淋球菌耐药监测点 PPNG 及相应 blaTEm-135突变体阳性率处于较高水平,不同地区间 PPNG 及相应 blaTEm-135突变体阳性菌株 ST 型别分布差异有统计学意义。 Objective To determine the prevalence of penicillinase-producing Neisseria gonorrhoeae(PPNG) and the distribution of blaTEm-135 gene variants in PPNG at several gonococcal antimicrobial surveillance sites in China, to compare N. gonorrhoeae multi-antigen sequence typing(NG-MAST)types of PPNG and its blaTEm-135 gene variants, and to assess the difference and association in NG-MAST types of blaTEm-135 gene variants among different regions. Methods A total of 572 N. gonorrhoeae isolates were collected at 6 gonococcal antimicrobial surveillance sites from Jiangsu, Shanghai, Zhejiang, Tianjin, Guangdong and Guangxi in 2012. After isolation, purification, and identification, cefalotin paper discs were used for detection of PPNG. DNA was extracted by QIAxtractor DX kits after cultivation of the PPNG strains. Then, mismatch amplification mutation assay (MAMA) PCR was performed to identify blaTEm-135 variants, and NG-MAST analysis to determine N. gonorrhoeae genotypes. Results Among the 572 N. gonorrhoeae strains, 38.1%(218/572) were identified as PPNG, and of the PPNG strains, 52.3% (114/218) were blaTEm-135 variants. The detection rate of PPNG at these surveillance sites from high to low was as follows: 51.7% (45/87, Zhejiang), 45.6%(36/79, Shanghai), 38.0% (78/205, Guangdong), 37.5% (12/32, Guangxi), 31.2% (24/77, Jiangsu) and 25.0%(23/92, Tianjin), and that of blaTEm-135 variants was as follows: 68.9%(31/45, Zhejiang), 58.3%(14/24, Jiangsu), 50.0%(39/78, Guangdong), 47.2%(17/36, Shanghai), 39.1%(9/23, Tianjin)and 33.3%(4/12, Guangxi). NG-MAST analysis showed that the ST2318, ST1768, ST1866, ST1053 and ST8726 types predominated among these bla TEm-135 variants, and a strong correlation was found between blaTEm-135 variants and some NG-MAST types, such as ST1768, ST1053 and ST8726 types. The distribution of NG-MAST types was significantly different between the surveillance site in Tianjin (in the Northern part of China) and the other sites (in the Southern part of China), but highly similar among the surveillance sites in Jiangsu, Zhejiang and Shanghai regions. Conclusions There is a high prevalence of PPNG and its blaTEm-135 variants at several gonococcal antimicrobial surveillance sites in China, with significant differences in NG-MAST genotype distribution of PPNG and its blaTEm-135 variants among different regions.
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2015年第5期312-316,共5页 Chinese Journal of Dermatology
基金 国家自然科学基金青年科学基金(81101294) 协和青年基金暨中央高校基本科研业务费专项资金(3332013143)
关键词 奈瑟球菌 淋病 Β内酰胺酶类 流行病学 blaTEM-135突变体 NG—MAST Neisseffa gonorrhoeae beta-Lactamases Epidemiology blaTEM-135 Gene variant Neisseria gonorrhoeae multi-antigen sequence typing
  • 相关文献

参考文献16

  • 1Ashford WA, Golash RG, Hemming VG. Penicillinase-producing Neissea gonorrhoeae[J]. Lancet, 1976, 2(7987): 657-658.
  • 2Phillips I. Beta-lactamase-producing, penicillin-resistant gonococcus [ J ]. Lancet, 1976, 2(7987 ): 656-657.
  • 3Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: detailed characterization of the first strain with high-level resistance to ceftriaxone[ J ]. Antimicrob Agents Chemother, 2011, 55 (7): 3538- 3545.
  • 4Unemo M, Golparian D, Nicholas R, et al. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure [ J ]. Antimicrob Agents Chemother, 2012, 56 ( 3 ): 1273-1280.
  • 5Ctmara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftrlaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain [J ]. J Antimicrob Chemother, 2012, 67 (8): 1858-1860.
  • 6Ison CA, Hussey J, Sankar KN, et al. Gonorrhoea treatment failures to cefixime and azithromycin in England, 2010 [J/OL]. Euro Surveill, 2011, 16 (14). pii: 19833 [2014-10-10]. http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId= 19833.
  • 7Unemo M, Golparian D, Hestner A. Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations, Sweden, July 2010[J/OL]. Euro Surveill, 2011, 16(6). pii: 19792 [2014-10-10]. http://www.eurosurveillance.org/ViewArticle.aspx? Article/d= 19792.
  • 8Unemo M, Golparian D, Syversen G, et al. Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment, Norway, 2010 [J/OL]. Euro Surveill, 2010, 15 (47). pii: 19721 [2014-10-10]. http://www. eurosurveillanee.org/ViewArticle.aspx?Articleld= 19721.
  • 9Unemo M, Golparian D, Potocnik M, et al. Treatment failure of pharyngeal gonorrhoea with internationally recommended first-line ceftriaxone verified in Slovenia, September 2011 [J/OL]. Euro Surveill, 2012, 17 (25). pii: 20200 [2014-10-10]. http://www. eurosurveillance.org/ViewArticle.aspx?Artieleld=20200.
  • 10Tapsall J, Read P, Carmody C, et al. Two cases of failed eeftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods [J]. J Med Microbiol, 2009, 58 (5): 683- 687.

二级参考文献14

  • 1Ohnishi M,Golparian D,Shimuta K,et al.Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?:detailed characterization of the first strain with high-level resistance to ceftriaxone[J].Antimicrob Agents Chemother,2011,55(7):3538-3545.
  • 2Unemo M,Golparian D,Nicholas R,et al.High-level cefiximeand ceftriaxone-resistant Neisseria gonorrhoeae in France:novel penA mosaic allele in a successful international clone causes treatment failure[J].Antimicrob Agents Chemother,2012,56(3):1273-1280.
  • 3Camara J,Serra J,Ayats J,et al.Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia,Spain[J].J Antimicrob Chemother,2012,67(8):1858-1860.
  • 4Ison CA,Hussey J,Sankar KN,et al.Gonorrhoea treatment failures to cefixime and azithromycin in England,2010[J].Euro Surveill,2011,16(14):19833.
  • 5Unemo M,Golparian D,Hestner A.Ceftriaxone treatment failure of pharyngeal gonorrhoea verified by international recommendations,Sweden,July 2010[J].Euro Surveill,2011,16(6):19792.
  • 6Unemo M,Golparian D,Syversen G,et al.Two cases of verified clinical failures using internationally recommended first-line cefixime for gonorrhoea treatment,Norway,2010[J].Euro Surveill,2010,15(47):19721.
  • 7Heymans R,Bruisten SM,Golparian D,et al.Clonally related Neisseria gonorrhoeae isolates with decreased susceptibility to the extended-spectrum cephalosporin cefotaxime in Amsterdam,the Netherlands[J].Antimicrob Agents Chemother,2012,56(3):1516-1522.
  • 8Tapsall J,Read P,Carmody C,et al.Two cases of failed ceftriaxone treatment in pharyngeal gonorrhoea verified by molecular microbiological methods[J].J Med Microbiol,2009,58(Pt 5):683-687.
  • 9Yokoi S,Deguchi T,Ozawa T,et al.Threat to cefixime treatment for gonorrhea[J].Emerg Infect Dis,2007,13(8):1275-1277.
  • 10Clinical and Laboratory Standards Institute (CLSI).Performance standards for antimicrobial susceptibility testing:twenty-first informational supplement[M].Clinical and Laboratory Standards Institute (CLSI),2011.

共引文献8

同被引文献23

引证文献4

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部